Creative Biolabs offers a variety of customarily prepared antibody-drug conjugate (ADC) products to serve the course of ADC development and evaluation. Taken advantage of our large inventory of therapeutic antibodies, our scientists help create the custom ADC products by conjugating therapeutic antibodies against cancer surface antigens with different drug-linker complexes. These high-quality custom ADCs are suitable for tasks such as proof-of-concept, target validation, as well as control to provide comparison in efficacy for new ADC development projects.

The customized ADC products are target-oriented. A full list of ADC-targeting cancer surface antigens is available here: